High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
2006

High Sensitivity Assays for Docetaxel and Paclitaxel in Plasma

Sample size: 15 publication Evidence: moderate

Author Information

Author(s): Andersen Anders, Warren David J, Brunsvig Paal F, Aamdal Steinar, Kristensen Gunnar B, Olsen Harald

Primary Institution: The Norwegian Radium Hospital

Hypothesis

Can high-performance liquid chromatography (HPLC) methods be developed to monitor taxane levels in patients receiving low-dose therapy?

Conclusion

The developed HPLC method can accurately quantify docetaxel and paclitaxel in plasma at low concentrations, which is useful for pharmacokinetic studies.

Supporting Evidence

  • The method can quantify docetaxel down to 1 nM in plasma samples.
  • Paclitaxel can be quantified down to 1.2 nM with acceptable accuracy.
  • The study included patients receiving both low and high doses of the drugs.

Takeaway

Researchers created a new way to measure cancer drugs in the blood, which helps doctors understand how well the treatment is working.

Methodology

The study used solid-phase extraction followed by high-performance liquid chromatography with UV detection to analyze plasma samples from patients.

Limitations

The method may require further validation in larger patient populations and different clinical settings.

Participant Demographics

10 patients receiving paclitaxel and 5 patients receiving docetaxel, with varying doses.

Digital Object Identifier (DOI)

10.1186/1472-6904-6-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication